Bangladesh defied Big Pharma to create a thriving low-cost generic drug industry – with regulation and policy lessons for India, Southasia and the world
Recurring exposés reveal massive gaps in drug safety in India’s pharma industry, as regulatory failures, lax laws, loopholes and lobbying leave millions in India, Southasia and the world at risk
Deadly Indian cough syrups in The Gambia and beyond point to shocking disparities in drug regulation for the world’s rich and poor, with the World Health Organisation failing to protect vulnerable countries
